课题基金 / 基金详情

Glutamatergic compounds for treating drug addiction: Preclinical models

Glutamatergic compounds for treating drug addiction: Preclinical models
用于治疗药物成瘾的谷氨酸化合物：临床前模型
批准号：
9353054
负责人：
Eliot Gardner
金额：
$50.89万
依托单位：
NATIONAL INSTITUTE ON DRUG ABUSE
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/9353054
关键词：
Addictive BehaviorAnimal ModelBehaviorBiochemicalBiological AssayBrainBudgetsChemicalsCollaborationsCuesDrug AddictionDrug IndustryElectrical Stimulation of the BrainExposure toGlutamatesGoalsHigh Pressure Liquid ChromatographyImmunoblottingIntravenousLaboratory AnimalsLiteratureMediatingMetabotropic Glutamate ReceptorsMicrodialysisNeurotransmittersPeer ReviewPharmaceutical PreparationsPolymerase Chain ReactionPre-Clinical ModelProteinsPsychological reinforcementPublicationsRNARelapseReportingResearchResearch Project GrantsReverse TranscriptionRewardsRoleSamplingSelf AdministrationStressSystemTechniquesWestern BlottingWorkaddictioncravingfollow-upin vivointerestpre-clinicalpreference

项目摘要

项目成果

Eliot Gardner的其他基金

相似基金

相关文献

中文摘要
翻译
由于预算和人员编制的极大削减，本报告所述期间，这一研究项目没有取得任何进展。这是不幸的，因为该项目在前几年一直是我们最有成效的研究努力之一，导致在同行评议的科学文献中发表了大量文章。我们目前正在寻求外部研究合作，特别是与制药行业内的实体合作，这可能使我们能够再次开展这项工作，并跟进我们在前几年就这一项目获得的有希望的发现。
英文摘要
Due to extremely severe cuts in budget and staffing, no progress was made on this research project during the reporting period. This is unfortunate, as this project had been - in previous years - one of our most productive research endeavors, resulting in a large number of publications in the peer-reviewed scientific literature. We are presently pursuing external research collaborations, especially with entities within the pharmaceutical industry, that may allow us to once again pursue this work and follow up on the promising findings that we had obtained in previous years on this project.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Basic brain mechanisms underlying drug addiction, craving, and relapse
Basic brain mechanisms underlying drug addiction, craving, and relapse
Endocannabinoid brain mechanisms and addiction
Dopamine D3 receptor antagonists for treating drug addiction: Preclinical models
海外基金